Arnold A. Pinkston - 22 Apr 2025 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
Director
Signature
/s/ Arnold A. Pinkston
Issuer symbol
BIO
Transactions as of
22 Apr 2025
Net transactions value
$0
Form type
4
Filing time
24 Apr 2025, 17:15:14 UTC
Previous filing
10 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO BIO.B Bio-Rad A Common Stock Options Exercise $0 +308 $0.000000 308 22 Apr 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIO.B Restricted Stock Units Award $0 +407 $0.000000 407 22 Apr 2025 Bio-Rad A Common Stock 407 $0.000000 Direct F2, F3
transaction BIO BIO.B Restricted Stock Units Options Exercise $0 -308 -100% $0.000000 0 22 Apr 2025 Bio-Rad A Common Stock 308 $0.000000 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3 The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders.
F4 On September 6, 2024, the reporting person was granted 308 restricted stock units, vesting at 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders.